Table 1. The baseline characteristics of all study participants.
Characteristics | Patients (n = 606) | Controls (n = 633) |
Age (years) | 54.36±12.33 | 55.15±9.38 |
Family history of other cancers | 10.56% | 0% |
Menarche age (years) | 14.60±1.63 | NA |
≤12 | 22.44% | NA |
13–14 | 37.13% | NA |
15 + | 40.43% | NA |
Menopausal status | ||
Premenopause | 50.17% | NA |
Postmenopause | 49.83% | NA |
Tumor size (T1–T4) | ||
T1 | 49.80% | NA |
T2 | 42.54% | NA |
T3 | 3.83% | NA |
T4 | 3.83% | NA |
Tumor grade (G1–G3) | ||
G1 | 4.87% | NA |
G2 | 50.81% | NA |
G3 | 44.32% | NA |
Lymph node (+) | 42.13% | NA |
Data were expressed as mean ± standard deviation unless otherwise indicated.